Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A robust approach to enhance tumor-selective accumulation of nanoparticles.

Qiao Y, Huang X, Nimmagadda S, Bai R, Staedtke V, Foss CA, Cheong I, Holdhoff M, Kato Y, Pomper MG, Riggins GJ, Kinzler KW, Diaz LA Jr, Vogelstein B, Zhou S.

Oncotarget. 2011 Jan-Feb;2(1-2):59-68.

2.

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.

Pérez-Herrero E, Fernández-Medarde A.

Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Review.

PMID:
25813885
3.

Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.

Sinek J, Frieboes H, Zheng X, Cristini V.

Biomed Microdevices. 2004 Dec;6(4):297-309.

PMID:
15548877
4.

In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.

Garcia-Bennett A, Nees M, Fadeel B.

Biochem Pharmacol. 2011 Apr 15;81(8):976-84. doi: 10.1016/j.bcp.2011.01.023. Epub 2011 Feb 12.

PMID:
21300030
5.

Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.

Hwang HY, Kim IS, Kwon IC, Kim YH.

J Control Release. 2008 May 22;128(1):23-31. doi: 10.1016/j.jconrel.2008.02.003. Epub 2008 Feb 20.

PMID:
18374444
6.

Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.

MacEwan SR, Callahan DJ, Chilkoti A.

Nanomedicine (Lond). 2010 Jul;5(5):793-806. doi: 10.2217/nnm.10.50. Review.

7.

Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.

Choi SH, Byeon HJ, Choi JS, Thao L, Kim I, Lee ES, Shin BS, Lee KC, Youn YS.

J Control Release. 2015 Jan 10;197:199-207. doi: 10.1016/j.jconrel.2014.11.008. Epub 2014 Nov 14.

PMID:
25445703
8.

Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy.

Lv L, Guo Y, Shen Y, Liu J, Zhang W, Zhou D, Guo S.

Adv Healthc Mater. 2015 Jul 15;4(10):1496-501, 1423. doi: 10.1002/adhm.201500075. Epub 2015 Jun 1.

PMID:
26033838
9.

Nanotechnology: Carrying drugs.

Bourzac K.

Nature. 2012 Nov 22;491(7425):S58-60. No abstract available.

PMID:
23320289
10.

Critical role of molecular imaging for substantially improved anticancer therapy.

Park K.

J Control Release. 2010 Oct 15;147(2):153. doi: 10.1016/j.jconrel.2010.09.002. Epub 2010 Sep 9. No abstract available.

PMID:
20831886
11.

Role of integrated cancer nanomedicine in overcoming drug resistance.

Iyer AK, Singh A, Ganta S, Amiji MM.

Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21. Review.

PMID:
23880506
12.

Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.

Wu SK, Chiang CF, Hsu YH, Lin TH, Liou HC, Fu WM, Lin WL.

Int J Nanomedicine. 2014 Sep 19;9:4485-94. doi: 10.2147/IJN.S68347. eCollection 2014.

13.

Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.

Sultana S, Khan MR, Kumar M, Kumar S, Ali M.

J Drug Target. 2013 Feb;21(2):107-25. doi: 10.3109/1061186X.2012.712130. Epub 2012 Aug 9. Review.

PMID:
22873288
14.

The ligand nanoparticle conjugation approach for targeted cancer therapy.

Karra N, Benita S.

Curr Drug Metab. 2012 Jan;13(1):22-41. Review.

PMID:
21892918
15.

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.

Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC.

J Control Release. 2008 May 8;127(3):208-18. doi: 10.1016/j.jconrel.2008.01.013. Epub 2008 Feb 7.

PMID:
18336946
16.

Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.

Cegnar M, Kristl J, Kos J.

Expert Opin Biol Ther. 2005 Dec;5(12):1557-69. Review.

PMID:
16318420
17.

Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.

Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, Jo HG, Park JH, Choi K, Jeong SY, Park RW, Kim IS, Kim K, Kwon IC.

J Control Release. 2008 Apr 7;127(1):41-9. doi: 10.1016/j.jconrel.2007.12.014. Epub 2007 Dec 26.

PMID:
18234388
18.

Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.

Park K, Kim JH, Nam YS, Lee S, Nam HY, Kim K, Park JH, Kim IS, Choi K, Kim SY, Kwon IC.

J Control Release. 2007 Oct 8;122(3):305-14. Epub 2007 Apr 19.

PMID:
17643545
19.

Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.

Bhunchu S, Rojsitthisak P.

Pharmazie. 2014 Aug;69(8):563-70.

PMID:
25158565
20.

Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization.

Lu X, Howard MD, Mazik M, Eldridge J, Rinehart JJ, Jay M, Leggas M.

AAPS J. 2008;10(1):133-40. doi: 10.1208/s12248-008-9013-z. Epub 2008 Mar 4.

Supplemental Content

Support Center